John Devlin

Professor, Director, Critical Care Pharmacy Fellowship Program
  • Department of Pharmacy Practice
  • School of Pharmacy

Office: 140 The Fenway, R218D
Phone: 617-373-8171

Post-doctoral research fellow, Henry Ford Hospital, Detroit, MI
Practice Residency, London Health Sciences Center, London, CA
Doctor of Pharmacy, University of Toronto
Bachelors of Science in Pharmacy, University of Toronto

Specializations: Critical Care

 American Association of Colleges of Pharmacy (ACCP) Critical Care PRN Research Award
 Society of Critical Care Medicine Pharmacy Fellowship Research Award
 Society of Critical Care Medicine Pharmacy Specialty Research Award
 Fellowship, American College of Clinical Pharmacy Fellow (FCCP)
 Society of Critical Care Medicine Joseph F. Dasta Critical Pharmacy Research Grant
 Fellowship, American College of Critical Care Medicine 
 Society of Critical Care Medicine Nursing Section Research Award

Community and Professional Service: 
Board member, Community Research Initiative of New England
Editorial Board, Critical Care Medicine
Editorial Board, Pharmacotherapy
External grant reviewer, Canadian Institute for Health Research
External grant reviewer, German Ministry of Health
Member, International Consensus Conference: Acute care sedation: targeting delirium duration
Member, Food and Drug Administration Panel: Clinical development programs for sedation products
Member, Canadian Critical Care Trials Group
Member, American College of Critical Care Medicine Task Force: Guidelines for the recognition, prevention and treatment of pain, agitation and delirium in adult ICU patients
Member, American College of Critical Care Medicine Task Force:  Guidelines for the use of restraints in the ICU

Dr. Devlin, in collaboration with members of the Division of Pulmonary, Critical Care and Sleep Medicine and the Department of Psychiatry at Tufts Medical Center, directs a federally-funded, clinical research program surrounding the assessment and treatment of delirium and agitation in the intensive care unit.

Research Methods in Health Systems (PMD U585) This 5th year elective course will expose students to the research methods that health system pharmacists use most often when conducting research.
Critical Care Advance Practice Experience (PMD G441). This 6th year practice experience allows students to focus on either conducting clinical research in the ICU or providing clinical pharmacy services in the ICU.

101. Fongemie, J., Al-Qadheeb N.S., Estes, N.A., Roberts, R., Tongesketi, T., Ruthazer, R., & Devlin JW. (2013) Agreement between ICU clinicians and electrophysiology cardiologists for the initiation of a QTc-interval prolonging medication in critically ill patients with potential risk factors for Torsade de Pointes: a comparative, case-based evaluation. Pharmacotherapy (in press)
100. Al-Qadeeb N.S., O’Connor, H., White, A., Neidhardt, N., Albizati, M., Joseph, B., Roberts, R., Ruthazer, R., & Devlin, J.W. (2013) Antipsychotic use and outcomes in patients requiring prolonged mechanical ventilation at a long term acute care hospital. Annals of Pharmacotherapy (in press)
99. Al-Qadheeb, N.S., O’Connor, H., White, A., & Devlin, J.W. Agitation in patients requiring prolonged mechanical ventilation at a long term acute care hospital: Risk factors, outcomes and therapy. Journal of Intens Care Med (in press)
98. Al-Qadheeb, N.S., Hoffmeister, J., Roberts, R., Shanahan, K., Garpestad, E., & Devlin, J.W.  Critical care nurse and physician perceptions surrounding their nocturnal interactions with the other regarding pain, agitation and delirium. American Journal of Critical Care (in press)
97. Torbic, H., Papadopoulos, S., Manjourides, J., & Devlin, J.W..( 2013) Impact of a protocol advocating dexmedetomidine over propofol sedation after robotic-assisted, direct coronary artery bypass surgery on duration of mechanical ventilation and patient safety. Annals of Pharmacotherapy (in press) 
96. Devlin, J.W., Fraser, G.L., Ely, E.W., Kress, J.P., Skrobik, Y., & Dasta, J.F. (2013) Pharmacological management of sedation and delirium in mechanically ventilated ICU patients.  Sem Respir Crit Care Medicine (in press)
95. Pun, B., & Devlin, J.W. (2013) Delirium assessment tools in critical care. Sem Respir Cril Care Medicine (in press)
94. Barr, J., Fraser, G.L., Puntillo, K., Ely, E.W.,Gelinas, C., Dasta, J.F., Davidson, J.E., Devlin,  J.W.,  Kress, J.P.,Joffe, A., Coursin, D.B., Herr, D., Tung, A., Robinson, B.R.H., Fontaine, D., Ramsay, M., Riker, R., Sessler, C.N., Pun, B., Skrobik, Y., & Jaeschke, R. (2013) Clinical practice guidelines for the management of pain, agitation and delirium in adult ICU patients. Critical Care Medicine (in press January 2013)
93. Barr, J., Fraser, G.L., Puntillo, K., Ely, E.W.,Gelinas, C., Dasta, J.F., Davidson, J.E., Devlin,  J.W.,  Kress, J.P.,Joffe, A., Coursin, D.B., Herr, D., Tung, A., Robinson, B.R.H., Fontaine, D., Ramsay, M., Riker, R., Sessler, C.N., Pun, B., Skrobik, Y., & Jaeschke, R. (2013) Clinical practice guidelines for the management of pain, agitation and delirium in adult ICU patients: Executive summary. American Journal of Health-System Pharmacy: 70;53-58.
92. Devlin, J.W., Brummel, N., & Al-Qadheeb, N.S. (2012) Optimizing the recognition of delirium in the critically ill. Best Practices and Research in Clinical Anaesthesioliolgy; 26(3):385-93.
91. Devlin, J.W., Alqadheeb, N.S., & Skrobik, Y. (2012) Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalized patients: a review of data from prospective, randomized studies. Best Practices and Research in Clinical Anaesthesiology; 26(3); 289-309.
90. Devlin, J.W., Al-Qadheeb ,N.S., & Riker R. R. (2012)  Sedation, nighttime, icebergs, and the titanic. Critical Care Medicine Oct; 40(10):2905-6.
89. Bhat S, Roberts R, & Devlin JW. (2012) Posted versus actual drug shortages. American Journal Health-System Pharmacy; 15; 69(16):1363-4.    
88. Mehta, S., Burry L., Cook, D., Fergusson, D., Steinburg, M., Granton, J., Herridge, M., Ferguson, N., Devlin, J.W., Tanios, M., Dodek, P., Fowler, R., Burns, K., Jacka, M., Olafson, K., Skrobik, Y., Hebert, P., Sabri, E., & Mead, M.A. for the Canadian Critical Care Trials Group. A randomized trial of daily sedative interruption in mechanically ventilated critically ill patients cared for with a sedation protocol. JAMA Nov 21;308(19):1985-92.
87. Al-Qadheeb, N.S., Roberts, R., Griffin, R., Garpestad, E., Ruthazer, R., & Devlin, J.W. (2012) Impact of enteral methadone on the ability to wean continuously-infused opioids in critically ill, mechanically ventilated adults: A case-control study. Annals of Pharmacotherapy; Sept 46(9): 1160-6. 
86. Gesin, G., & Devlin, J.W. (2012) Response: Delirium diagnosis: what you do with the information matters most. American Journal Critical Care May; 21(3):154-5.
85. Devlin, J.W., & Skrobik, Y. (2012) The Kynurenine pathway: a metabolinomic pathway for ICU delirium? Critical Care Medicine 40(3):1001-2
84. Devlin, J.W., & Al-Qadheeb, N.S. (2012). An ACE in the hole for evaluating cognition in the ICU? Critical Care Medicine Jan; 40(1):324-6
83. Kher. S., Roberts, R.J., Garpestad, E., Howard, H., Kunkel,, C., Didomenico, D., Ferguson, A., & Devlin, J.W. (2012) Development, implementation and evaluation of an institutional daily awakening and spontaneous breathing trial protocol: a process improvement project. Journal Intensive Care Medicine (ahead of press May 14)
82. Gesin, G., Lin, A., Russell, B., Norton, H., Evans, S., & Devlin, J.W. (2012). Impact of a delirium screening tool, with or without a multifaceted education program supporting its use, on nurse knowledge and ability to correctly evaluate delirium in a surgical trauma intensive care unit. American Journal Critical Care Jan;21(1):e1-e11.80
81. Roberts, R., Chi, A., Grover, A., Newman, M., Bhat, S., Benotti, S., Garpestad, E., Nasraway, S., & Devlin, J. W. (2012) Impact of a national propofol shortage on duration of mechanical ventilation at an academic medical center. Critical Care Medicine Feb; 40(2):406-11
80. Devlin, J.W., Skrobik, Y., Hinderleider, E., Roberts, R., Fong, J.J., Riker, R., Ruthazer, R., Hill, N. S., & Garpestad, E. (2011). Impact of quetiapine on the resolution of individual delirium symptoms in critically Ill patients with delirium: a double-blind, randomized, placebo-controlled pilot study. Critical Care Sep17;15(5):R215
79. Devlin, J.W., Bhat, S., Roberts, R.J, & Skrobik, Y. (2011). Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight States. Annals of Pharmacotherapy 45: 1217-29
78. Devlin, J.W., & Roberts, R.J.(2011). Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol and opioids. Anesthesiology Clinics Dec;29(4):567-8
77. Devlin JW, & Skrobik Y. (2011) Antipsychotics for the prevention and treatment of delirium in the ICU: What is their role? Harvard Review of Psychiatry 19:1-9
76. Devlin, J.W,  Roberts, R., Fong, J.J., Skrobik, Y., Riker R.R., Hill, N.S., & Garpestad, E. (2010) Efficacy and safety of quetiapine for delirium in the ICU: A randomized, double-blind, placebo- controlled pilot study.  Critical Care Medicine. Feb;38(2):419-27
75. Szczech, L.A., Granger, C.B., Dasta, J.F., Amin, A, Peacock W.F., Devlin J.W., Weir, M.R., Wyman, A., Katz, J.N., & Varon J., for the STAT Investigators. (2010). Mild acute kidney injury is associated with worse outcomes in acute hypertension. Circulation 121(20):2183-91
74. Roberts RJ, de Wit M, Epstein SK, Didomenico D, & Devlin J.W. (2010). Predictors for daily interruption of sedation therapy by nurses: a prospective, multicenter study. Journal of Critical Care; 25(4):660.e1-7
73. Devlin, J.W., Dasta, J.F., Kleinschidt, K.,  Roberts, R.J., Lapointe, M., Varon, J., Anderson, F.A., Wyman, A., & Granger, C.B. Studying the Treatment of Acute Hypertension (STAT) Investigators. (2010).  Acute pharmacological therapy and blood pressure control in the management of hospitalized patients with severe hypertension. Pharmacotherapy 30(11):1087-96
72. Gore, J.M., Peterson, E., Amin, A., Anderson, F.A. Jr, Dasta, J.F., Levy, P.D., O'Neil, B.J., Sung, G.Y., Varon, J., Wyman, A., & Granger, C.B. for the STAT Investigators (2010). Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study. American Heart Journal. Sep;160 (3):521-527.e1
71. Devlin, J.W., Garpestad, E., & Hill, N.S.(2010) Neuromuscular blockers in acute respiratory distress syndrome. New  England Journal of Medicine. Dec 23;363(26):2562
70. Devlin, J.W., Mallow-Corbett, S., Riker, R.R. (2010)  Adverse drug events associated with the use of analgesics, sedatives and antipsychotics in the intensive care unit. Critical Care Medicine Jun;38(6 Suppl):S231-43
69. Skrobik, Y., & Devlin, J.W. (2010) The Intensive Care Delirium Screening Checklist has many potential benefits over the Nursing Delirium Screening Scale. Critical Care Medicine.38:1610-1
68. Tanios, M.A., Epstein S.K., de Wit, M., & Devlin, J.W. (2009). Perceived barriers to the use of sedation protocols and daily sedation interruption. A multidisciplinary survey. Journal of Critical Care 24;66-73
67. Katz, J.N, Fore, J.M., Amin, A., Anderson, A., Dasta J.F., Ferguson, J.J., Kleinschmidt, K., Mayer, S. A., Multz, M.A., Peacock, W.F., Peterson, E for the STAT Investigators. Practice patterns, outcomes and end-organ dysfunction for patients with acute severe hypertension: The Studying the Treatment of Acute  Hypertension (STAT) Registry.  American Heart Journal; 158:599-606.
66. Roberts, R. Barletta, J., Fong, J., Schumaker, G., Gerlach, T., Voils, S., Kuper, P., Szumita, P., Anger, K., Papadopoulos, S., Grgurich, P., Kendall, E., Xamplas, R., Arpino, P., Ruthazer, R., & Devlin, J.W. (2009). Incidence of the propofol infusion syndrome in critically ill adults. Critical Care. Oct 29;13(5):R169
65. Fong, J.J., & Devlin, J.W., (2009) Can post-operative delirium be prevented pharmacologically?  Critical Care Medicine 37:1825-6
64. Devlin, J.W., & Roberts R. (2009) Pharmacology of commonly used sedatives and analgesics in the ICU. Critical Care Clinics 25: 431-49
63. Erstad, B.L., Brophy, G.M., Martin, S.M., Haas, C.E., Devlin, J.W., Welage, L.S., Dager, W. (2009) Articles and guidelines relative to intensive care unit pharmacology: a 2009 update. Pharmacotherapy; 29(10):1228-69
62. Devlin, J.W., Fong J., Howard, E., Skrobik, Y., McCoy N., Yasuda C., & Marshall, J. (2008). Assessment of delirium in the intensive care unit: Nursing practices and perceptions. American Journal of Critical Care 17:555-65
61. Fong, J., Sylvia, L., Ruthazer, R., Schumaker, G., KComt, M., & Devlin, J.W., (2008). Predictors of mortality in patients with propofol infusion syndrome. Critical Care Medicine 36:2281-7.
60. Lancaster, J., Lawrence, K., Fong, J., Doron, S., Garpestad, E., Nasraway S, & Devlin, J.W. (2008). Impact of an institutional hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes. Pharmacotherapy. 28:852-62.
59. Olsen, K.M., Devlin, J.W. (2008). Comparison of oral and intravenous lansoprazole pharmacodynamic response in the critically ill. Alimentary Pharmacology and Therapeutics, 28:326-333
58. Metz, D.C., Devlin, J.W., Vakily, M., Atkinson, S., & Lloyd, S. (2008). Administering lansoprazole 30 mg as a 2-minute intravenous injection provides greater immediate gastric acid suppression than a 30-minute infusion Pharmacotherapy,28:301-7
57. Devlin, J.W., Marquis, F., Riker, R.R., Robbins, T., Garpestad, E., Fong, J.J., Didomenico, D. & Skrobik, Y.S. (2008). Combined didactic and scenario-based education improves the ability of ICU staff to recognize delirium at the bedside. Critical Care,12:R19
56. Devlin, J.W. (2008) The pharmacology of oversedation in mechanically ventilated adults. Current Opinions in Critical Care 14:403-7
55. De Wit, M., & Devlin, J.W. (2008). Should sedation be standardized in the ICU? Critical Care Medicine, 36:1649-51
54. Roberts, R., Welch, S., & Devlin, J.W. (2008) Corticosteroids for the prevention of post-extubation laryngeal edema in adults. Annals of Pharmacotherapy, 42:686-91
53. Barletta, J.F., Devlin, J.W. (2008). Sedation with dexmedetomidine vs lorazepam in mechanicall ventilated patients. Journal of the American Medical Association, 299:1541
52. Devlin, J.W., Nasraway, S.A. (2008). Reversing oversedation in the ICU: The role of pharmacists in energizing guideline efforts and overcoming protocol fatigue. Critical Care Medicine,36:626-8.
51. Devlin, J.W., Fong, J.J., Schumaker, G., Ruthazer, R., O’Connor, H. & Garpestad, E. (2007). Use of a validated delirium assessment tool improves the ability of physicians to recognize delirium in medical intensive care unit (MICU) patients. Critical Care Medicine, 35; 2721-4
50. Van Amburgh, J., Devlin, J.W., Kirwin, J., & Qualters, D. (2007) The active learning inventory: A tool to measure active learning in the classroom. American Journal of Pharmacy Education,71:85-93
49. Fong, J.J., Kanji, S., Dasta, J., Garpestad, E., & Devlin, J.W. (2007). Propofol is associated with a shorter duration of
mechanical ventilation than scheduled intermittent lorazepam: A database analysis using Project IMPACT. Annals of Pharmacotherapy, 41:1986-1991
48. Devlin, J.W., Nava, S., Fong, J.J., & Hill, N.S. (2007). Survey of sedation practices during noninvasive positive-pressure ventilation to treat acute respiratory failure. Critical Care Medicine,35:2298-2302
47. Fong, J.J., Cecere, K., Klee, M., Garpestad, E., Unterborn, J., & Devlin, J.W. (2007).  Factors influencing variability in compliance rates and clinical outcomes among three different severe sepsis bundles. Annals of Pharmacotherapy, 41, 929-36
46. Devlin, J.W., Fong, J., Fraser, G., & Riker, R. (2007) Delirium assessment in the critically Ill. Intensive Care Medicine, 33, 929-40
45. Rea, R., Battistone, S., Fong, J., & Devlin, J.W. (2007). Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy, 27:588-594
44. Devlin, J.W., Bakshi, A., Bungay, K.M., & Olsen, K.M. (2006) An in vitro comparison of different providers to deliver four proton pump inhibitor (PPI) products through a feeding tube. Aliment Pharmacology and Therapeutics, 24,1603-1613
43. Kane-Gill, S., & Devlin, J.W.  (2006). Adverse drug event reporting in the intensive care unit: A survey of current practices. Annals of Pharmacotherapy,40,1267-1273
42. MacLaren, R., Devlin, J.W., Martin, S.J., Dasta, J.F., Rudis, M.I., & Bond, C.A. (2006). A national survey characterizing the practice of critical care pharmacists. Annals of Pharmacotherapy, 40, 612-618
41. Devlin, J.W., Tanios, M., & Epstein, S.K. (2006). ICU sedation: Waking up clinicians to the gap between research and practice. Critical Care Medicine, 34, 556-557
40. Devlin, J.W., & Olsen, K.M. (2006).Proton pump inhibitor formulary considerations in the acutely ill: Part 1: Pharmacology, pharmacodynamics and available formulations. (Author’s reply). Ann Pharmacother, 40, 997-998
39. Devlin, J.W., Fong, J.J., & Schumaker, G. (2006) Identifying factors that could account for differences in duration of mechanical ventilation between intermittent lorazepam and propofol-treated patients. Crit Care Med, 34, 3063-3064
38. Devlin, J.W., Lau, A.K., & Tanios, M. (2005). Propofol-associated hypertriglyceridemia and pancreatitis in the ICU: An incidence and risk factor analysis. Pharmacotherapy, 25,1348-1352
37. Ahrens, C.L., Barletta, J.F., Kanji, S., Tyburski, J.G., Wilson, R.F., Janisse, J.J., & Devlin, J.W. (2005). The effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: A randomized, controlled trial. Critical Care Medicine, 33, 2507-2512 
36. Devlin, J.W., & Barletta, J.F. (2005). Reevaluating the role of albumin for fluid resuscitation: Implications of the saline versus albumin fluid evaluation (SAFE). American Journal of Health System Pharmacy, 62, 637-642
35. Devlin, J.W., Welage, L.S., & Olsen, K.M.  (2005).Proton pump inhibitor formulary considerations in the acutely ill: Part 1: Pharmacology, pharmacodynamics and available formulations. Ann Pharm 2005, 39, 1667-1677
34. Devlin, J.W., Welage, L.S., & Olsen, K.M. (2005) Proton pump inhibitor formulary considerations in the acutely ill: Part 2: Clinical efficacy, safety and economics. Annals of Pharmacotherapy, 39, 1844-1851
33. Devlin, J.W. (2005).Treatment options and formulary considerations in the management of acid suppression in critically ill patients. American Journal of Health-System Pharmacy, 62(Suppl 2), S2-3
32. Devlin, J.W. (2005). Proton pump inhibitors for acid suppression in the intensive care unit: Formulary considerations. American Journal Health-System Pharmacy 62, (Suppl 2), S24-30
31. Devlin, J.W., Seta M.L., Kanji, S., & Somerville, A.L. (2004). Fenoldopam versus nitroprusside for the treatment of hypertensive emergency. Annals of Pharmacotherapy, 38, 755-759
30. Diebel, L.N., Liberati, D.M., Baylor, A.E., Brown, W.J., & Devlin, J.W. (2004). Immunogloobulin A protease is a virulence factor for gram-negative pneumonia. Surgery, 136, 937-943
29. Nguyen, C.M., Barletta, J.F., & Devlin J.W. (2004). Use of acid suppression agents following acute, non-variceal, upper gastrointestinal bleeding. Hospital Pharmacy, 39, 970-975
28. Devlin, J.W., & Welage, L.S. (2004). The cost effectiveness of proton pump inhibitors for bleeding peptic  ulcers: The
unanswered questions. Critical Care Medicine, 32, 1415-1416
27. Betancourt, M., McKinnon, P.S., Massanari, R.M., Kanji, S., Bach, D., & Devlin, J.W. (2003). An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failures. PharmacoEconomics, 21(18), 1331-1340
26. Kanji, S., McKinnon, P.S., Barletta, J.F., Kruse, J.A., & Devlin, J.W.(2003). Bioavailability of gatifloxacin by nasogastric administration with and without concomitant enteral feeding in critically ill patients. Critical Care Medicine, 31, 1347-1352
25. Maccioli, G.A., Dorman, T., Brown, B.R., Mazuski, J.E., McLean, B.A., Kuszaj, J.M., Rosenbaum, S.H., Frankel, L.R., & Devlin, J.W. (2003). Clinical practice guidelines for the maintenance of patient physical safety in the intensive care unit: Use of restraining therapies – American College of Critical Care Medicine Task Force 2001-2002. Critical Care Medicine, 31, 2665-2676
24. Kanji, S., Barletta, J.F., Janisse, J., Kruse, J.A., & Devlin, J.W. (2002). Tachyphylaxis associated with continuous cisatracurium versus pancuronium therapy. Pharmacotherapy, 22, 823-830
23. Delgado, G., Barletta J.F., Kanji, S., Tyburski, J.G., Wilson, R.F., & Devlin, J.W. (2002)Characteristics of prophylactic antibiotic strategies following penetrating abdominal trauma at a level one urban trauma center: A comparison to the EAST Guidelines. Journal of Trauma, 53, 673-678
22. Vanscoy, G., Devlin, J.W., Ponzillo, J., & Kuhl, D.A. (2002). Implementing guidelines for drotrecogin alfa (activated): Three perspectives. Pharmacy and Therapeutics, 27, 1-15
21. Devlin, J.W., & Kanji, S. (2002). Managing thrombosis syndromes. In: Critical Care Module, Pharmacy Self Assesssment Program (PSAP). 4th ed.  Zarowitz, BJ. (Ed). Kansas City, MO, American College of Clinical Pharmacy
20. Devlin, J.W., Tyburski, J.G., & Moed, B. (2001). Implementation and evaluation of enoxaparin deep vein thrombosis prophylaxis guidelines after major trauma. Pharmacotherapy, 21,740-747
19. McKinnon, P.S., Goff, D.A., Kern, J.W., Devlin, J.W., Barletta, J.F., Sierawski, S.J., Mosenthal, A.C., Gore, P., Ambegaonkar, A.J., & Lubowski, T.J. (2001) Temporal assessment of candida risk factors in the surgical intensive care unit. Archives of Surgery, 136, 1401-1409
18. Devlin, J.W., Fraser, G.F., Kanji, S., & Riker, R. (2001). Sedation assessment in critically ill adults.  Annals of Pharmacotherapy, 35, 1624-1632
17. Kanji, S., Devlin, J.W., Piekos, K., & Racine, E. (2001). Recombinant human activated protein C (drotrecogin alfa activated): A novel therapy for severe sepsis. Pharmacotherapy, 21, 1389-1402
16. Devlin, J.W., Coplin, W.M., Murry, K.R., Rengachary, S.S., & Wilson, R.F. (2000). Nimodipine induced acute hypoxemia. Neurosurgery, 47, 1243-1247
15. Devlin, J.W. (2000) Pain assessment in seriously ill patients: Can family members play a role? Crit Care Med 28, 1660-1661
14. Clemmer, T.P., Wallace, J.C., Spuhler, V.J., Bailey, P.P., & Devlin, J.W. (2000). Origins of the Motor Activity Assessment Scale score: A multi-institutional process. Critical Care Medicine 28, 3124.
13. Devlin, J.W. (2000). The role of low molecular weight heparin for DVT prophylaxis in acutely ill medical patients.  Journal of Informed Pharmacotherapy 2000; 3, 300-308.
12. Tyburski, J.G., Dente, C., Wilson, R.F., Steffes, C., Devlin, J.W., Carlin, A., & Shanti, C. (2001). Differences in arterial and mixed venous IL-6 levels: The lungs as a source of cytokine storm in sepsis. Surgery, 130, 748-752
11. Devlin, J.W., Boleski, G., Mlynarek, M., Nerenz, D., Peterson, E., Horst, H.M., & Zarowitz, B.J. (1999). The Motor Activity Assessment Scale: A valid and reliable sedation scale for use in adult, mechanically ventilated, surgical ICU patients. Critical Care Medicine, 27, 1271-1275
10. Mazur, J.E., Devlin, J.W., Peters, M.J., Jankowski, M., Iannuzzi, M.C., & Zarowitz, B.J. (1999) Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: A  randomized, double-blind trial. Critical Care Medicine, 27, 1257-1261
9. Devlin, J.W., Claire, K.S., Dulchavsky, S.A., &Tyburski, J.G. (1999). Impact of trauma stress ulcer prophylaxis guidelines on drug cost and incidence of major gastrointestinal bleeding. Pharmacotherapy, 19, 452-460
8. Devlin, J.W., Pettita, A., Shepard, A., & Obeid, F.N. (1998). Cost-effectiveness of enoxaparin versus low-dose heparin as prophylaxis against venous thrombosis after major trauma. Pharmacotherapy,18, 1335-1342
7. Devlin, J.W., Peters, M., Ulep, S., Ben-Menachem, T., Fogel, R., & Zarowitz, B.J. (1998). Stress ulcer prophylaxis in medical ICU patients: Annual utilization in relation to the incidence of endoscopically-proven stress-related gastritis. Annals of Pharmacotherapy, 32, 869-874
6. Makarechian, N., Agro, K.A., Devlin, J.W., Trepanier, E.R., Einarson, T., & Koren, G. (1998). Association between moderate alcohol consumption during pregnancy and spontaneous abortion, stillbirth, and premature birth: A meta-analysis. Canadian Journal of Clinical Pharmacology, 5(3),169-176
5. Devlin, J.W., Holbrook, A.M., & Fuller, H.D. (1997). The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Annals of Pharmacotherapy,31,689-695#
4. Devlin, J.W., Bailey, E.M., & Zarowitz, B.J. (1997). Administration of amphotericin B in lipid emulsion. Critical Care Medicine, 25, 892.
3. Devlin, J.W., Wass, H., & Waters, I.A. (1994). Fludarabine associated pulmonary hypersensitivity: a report of two cases. Canadian Journal of Hospital Pharmacy, 47, 125-127.
2. Devlin, J.W., Bayliff, C.D., & Paterson, N.A.M. (1990). Benzodiazepine withdrawal masqueradingas steroid psychosis. Canadian Journal of Hospital Pharmacy, 43,134-136.
1. Devlin, J.W., Bayliff, C.D., & Bellamy, N. (1992). Observations and effects of educational consults on allopurinol prescribing. Canadian Journal of Hospital Pharmacy, 45, 21-27.